Explore more publications!
Healthcare Today Michigan
Got News to Share?

Healthcare Today Michigan: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Michigan.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 16, 2026

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo
Mar. 16, 2026

Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo

Indeterminate GlobeNewswire
Flyte Launches Florida Hops to Service Accelerating Demand
Mar. 16, 2026

Flyte Launches Florida Hops to Service Accelerating Demand

Indeterminate GlobeNewswire
Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026
Mar. 16, 2026

Spyre Announces Acceleration of Expected Topline Readout of SKYWAY Rheumatoid Arthritis Sub-study to Q3 2026

Indeterminate GlobeNewswire
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold
Mar. 16, 2026

Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Therapeutic Threshold

Indeterminate GlobeNewswire
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
Mar. 16, 2026

Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26

Indeterminate GlobeNewswire
Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin
Mar. 16, 2026

Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin

Indeterminate GlobeNewswire
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
Mar. 16, 2026

Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Indeterminate GlobeNewswire
Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
Mar. 16, 2026

Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial

Indeterminate GlobeNewswire
Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager
Mar. 16, 2026

Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager

Indeterminate GlobeNewswire
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
Mar. 16, 2026

Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million

Indeterminate GlobeNewswire
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
Mar. 16, 2026

Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices

Indeterminate GlobeNewswire
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
Mar. 16, 2026

Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference

Indeterminate GlobeNewswire
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update
Mar. 16, 2026

CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire
Cronos Group Inc. to Speak at the 38th Annual ROTH Conference
Mar. 16, 2026

Cronos Group Inc. to Speak at the 38th Annual ROTH Conference

Indeterminate GlobeNewswire
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
Mar. 16, 2026

Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026

Indeterminate GlobeNewswire
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Mar. 16, 2026

Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

Indeterminate GlobeNewswire
MediciNova to Participate at the 38th Annual ROTH Conference
Mar. 16, 2026

MediciNova to Participate at the 38th Annual ROTH Conference

Indeterminate GlobeNewswire
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
Mar. 16, 2026

Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Mar. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Mar. 16, 2026

Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions